Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer.

Wan, Yanhui; Qian, Youhui; Wang, Youyu; Fang, Fuyuan; Wu, Guodong

Wan, Yanhui; Qian, Youhui; Wang, Youyu; Fang, Fuyuan; Wu, Guodong.

Afiliação

Wan Y; Department of Thoracic Surgery, the First Affiliated Hospital of Shenzhen University/Shenzhen Second People's Hospital, 3002 Futian Road , Shenzhen, 518000, China. c11231351@163.com.
Qian Y; Department of Thoracic Surgery, the First Affiliated Hospital of Shenzhen University/Shenzhen Second People's Hospital, 3002 Futian Road , Shenzhen, 518000, China.
Wang Y; Department of Thoracic Surgery, the First Affiliated Hospital of Shenzhen University/Shenzhen Second People's Hospital, 3002 Futian Road , Shenzhen, 518000, China.
Fang F; Department of Thoracic Surgery, the First Affiliated Hospital of Shenzhen University/Shenzhen Second People's Hospital, 3002 Futian Road , Shenzhen, 518000, China.
Wu G; Department of Thoracic Surgery, the First Affiliated Hospital of Shenzhen University/Shenzhen Second People's Hospital, 3002 Futian Road , Shenzhen, 518000, China.

Discov Oncol ; 13(1): 127, 2022 Nov 19.

Article em En | MEDLINE | ID: mdl-36401689

Palavras-chave

ALK; Beclin 1; EGFR; Non-squamous NSCLC; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google